Effect of semaglutide add‐on therapy for people living with type 1 diabetes and excess weight

Documenti analoghi

• Representation of women in randomized controlled trials of novel antidiabetic drugs: A cohort study
  di: Genya Aharon‐Hananel, et al.
  Pubblicazione: (2024)
• Glycaemic and weight effects of metabolic surgery or semaglutide in diabetes dosage for patients with type 2 diabetes
  di: Erik Stenberg, et al.
  Pubblicazione: (2024)
• Normoalbuminuria—is it normal? The association of urinary albumin within the ‘normoalbuminuric’ range with adverse cardiovascular and mortality outcomes: A systematic review and meta‐analysis
  di: Dvora R. Sehtman‐Shachar, et al.
  Pubblicazione: (2024)
• Effect of semaglutide on primary prevention of diabetic kidney disease in people with type 2 diabetes: A post hoc analysis of the SUSTAIN 6 randomized controlled trial
  di: Jingyu Wang, et al.
  Pubblicazione: (2024)
• Weight loss in people with type 1 diabetes over 12 months: Real‐world data comparing tirzepatide, semaglutide and liraglutide
  di: Ebaa Al Ozairi, et al.
  Pubblicazione: (2025)